Cannabinoids influence the metabolic and expression phenotype of cancer cells, including through epigenetic pathways; the conceptual framework links GPCR signaling (CB1/CB2) with chromatin remodeling and transcriptional reprogramming, which are hallmarks of cancer. Here, CNR1 is linked to cancer.